Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
24.93
-0.14 (-0.56%)
At close: Mar 6, 2026, 4:00 PM EST
24.91
-0.02 (-0.08%)
After-hours: Mar 6, 2026, 4:04 PM EST
Astrana Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 30.39 | 13.98 | 38.68 | 41.09 | 35.96 | Upgrade
|
| Other Revenue | 3,151 | 2,021 | 1,348 | 1,103 | 737.96 | Upgrade
|
| Revenue | 3,182 | 2,035 | 1,387 | 1,144 | 773.92 | Upgrade
|
| Revenue Growth (YoY) | 56.39% | 46.72% | 21.19% | 47.84% | 12.62% | Upgrade
|
| Cost of Revenue | 2,840 | 1,763 | 1,172 | 944.69 | 596.14 | Upgrade
|
| Gross Profit | 341.53 | 271.39 | 214.96 | 199.48 | 177.77 | Upgrade
|
| Selling, General & Admin | 217.26 | 154.11 | 112.6 | 77.67 | 62.08 | Upgrade
|
| Operating Expenses | 263.01 | 182.04 | 130.35 | 95.21 | 79.59 | Upgrade
|
| Operating Income | 78.53 | 89.35 | 84.61 | 104.27 | 98.18 | Upgrade
|
| Interest Expense | -49.93 | -33.1 | -16.1 | -7.92 | -5.39 | Upgrade
|
| Interest & Investment Income | 12.16 | 14.51 | 14.21 | 1.98 | 1.57 | Upgrade
|
| Earnings From Equity Investments | 1.71 | 4.45 | 5.58 | 5.62 | -4.31 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.79 | 4.88 | 4.88 | 2.57 | 3.92 | Upgrade
|
| EBT Excluding Unusual Items | 39.67 | 80.09 | 93.17 | 106.52 | 93.97 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.07 | 0.73 | -3.34 | -19 | -18.98 | Upgrade
|
| Other Unusual Items | - | - | - | -0.9 | 2.75 | Upgrade
|
| Pretax Income | 39.61 | 80.82 | 89.84 | 86.62 | 77.75 | Upgrade
|
| Income Tax Expense | 15.53 | 30.89 | 31.99 | 40.88 | 31.69 | Upgrade
|
| Earnings From Continuing Operations | 24.08 | 49.93 | 57.85 | 45.74 | 46.06 | Upgrade
|
| Minority Interest in Earnings | -1.59 | -6.78 | 2.87 | -0.57 | 22.87 | Upgrade
|
| Net Income | 22.49 | 43.15 | 60.72 | 45.17 | 68.92 | Upgrade
|
| Net Income to Common | 22.49 | 43.15 | 60.72 | 45.17 | 68.92 | Upgrade
|
| Net Income Growth | -47.88% | -28.93% | 34.42% | -34.46% | 82.88% | Upgrade
|
| Shares Outstanding (Basic) | 49 | 48 | 47 | 45 | 44 | Upgrade
|
| Shares Outstanding (Diluted) | 49 | 48 | 47 | 46 | 45 | Upgrade
|
| Shares Change (YoY) | 2.91% | 2.20% | 2.94% | 0.44% | 21.24% | Upgrade
|
| EPS (Basic) | 0.46 | 0.91 | 1.30 | 1.00 | 1.57 | Upgrade
|
| EPS (Diluted) | 0.46 | 0.90 | 1.29 | 0.99 | 1.52 | Upgrade
|
| EPS Growth | -49.09% | -30.23% | 30.30% | -34.87% | 50.50% | Upgrade
|
| Free Cash Flow | 104.49 | 44.17 | 39.7 | 59.19 | 51.11 | Upgrade
|
| Free Cash Flow Per Share | 2.12 | 0.92 | 0.85 | 1.30 | 1.13 | Upgrade
|
| Gross Margin | 10.73% | 13.34% | 15.50% | 17.43% | 22.97% | Upgrade
|
| Operating Margin | 2.47% | 4.39% | 6.10% | 9.11% | 12.69% | Upgrade
|
| Profit Margin | 0.71% | 2.12% | 4.38% | 3.95% | 8.91% | Upgrade
|
| Free Cash Flow Margin | 3.28% | 2.17% | 2.86% | 5.17% | 6.60% | Upgrade
|
| EBITDA | 124.27 | 117.28 | 102.36 | 121.81 | 115.7 | Upgrade
|
| EBITDA Margin | 3.91% | 5.76% | 7.38% | 10.65% | 14.95% | Upgrade
|
| D&A For EBITDA | 45.75 | 27.93 | 17.75 | 17.54 | 17.52 | Upgrade
|
| EBIT | 78.53 | 89.35 | 84.61 | 104.27 | 98.18 | Upgrade
|
| EBIT Margin | 2.47% | 4.39% | 6.10% | 9.11% | 12.69% | Upgrade
|
| Effective Tax Rate | 39.21% | 38.22% | 35.61% | 47.19% | 40.76% | Upgrade
|
| Revenue as Reported | 3,182 | 2,035 | 1,387 | 1,144 | 773.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.